Key Points
- Taiwan Semiconductor’s 2nm manufacturing lines remain completely reserved through 2028 and likely afterward
- NVIDIA faces possible architectural changes to its upcoming Feynman AI platform
- Meta competes directly with NVIDIA for identical TSMC manufacturing capacity
- Taiwan Semiconductor plans consecutive annual price increases extending to 2029 amid overwhelming demand
- Wall Street analysts continue recommending NVDA as a Strong Buy with $274.03 average target price
Shares of NVIDIA declined Monday following emerging reports that manufacturing constraints at Taiwan Semiconductor might compel the company to rework its Feynman AI platform architecture. NVDA closed down 3.28% during the session, while TSM experienced a 2.82% decrease.
According to initial reporting from Taiwan’s Economic Daily News, Taiwan Semiconductor’s cutting-edge 2-nanometer production facilities have reached maximum booking capacity extending to 2028, with reservations potentially stretching even further. Unprecedented demand from artificial intelligence and high-performance computing sectors has saturated available capacity at the globe’s dominant contract semiconductor manufacturer.
Feynman represents NVIDIA’s upcoming data center platform architecture, first revealed during the GTC 2026 conference. The platform serves as the designated successor to Vera Rubin and carries a targeted 2028 launch window.
The core challenge centers on availability: sufficient 2nm manufacturing capacity may prove inadequate to produce Feynman according to current specifications. This reality has prompted NVIDIA to evaluate potential architectural modifications well ahead of the platform’s scheduled debut.
Manufacturing Giant Faces Unprecedented Demand Surge
TSMC’s 2nm production nodes, particularly the enhanced A16 configuration, deliver efficiency improvements ranging from 15% to 25% compared to previous-generation fabrication processes. These capabilities have made the technology highly desirable for energy-intensive artificial intelligence applications.
NVIDIA faces substantial competition for these manufacturing slots. Meta has emerged as an aggressive competitor, placing orders for customized AI processors and graphics chips destined for its expanding data center infrastructure. Apple currently commands more than half of early 2nm production orders, effectively relegating other customers to extended waiting periods.
NVIDIA has reportedly secured approximately 20% of TSMC’s advanced manufacturing capacity and has reserved the majority of CoWoS advanced packaging capabilities extending through 2026. CEO Jensen Huang has allegedly engaged TSMC leadership directly to maximize production allocation.
Despite this preferential positioning, the company remains unable to escape the capacity constraints. Customer reservation queues now stretch past 2028, while TSMC has announced plans for yearly price escalations continuing through 2029 to balance escalating operational expenses.
Vera Rubin Platform Maintains Momentum
While Feynman encounters scheduling challenges, NVIDIA’s closer-term Vera Rubin platform continues progressing as planned. Vera Rubin production is scheduled to commence later this calendar year, preceding the Feynman deployment window.
NVIDIA has successfully locked in A16 manufacturing allocations for its Rubin Ultra lineup and subsequent GPU generations following Vera Rubin. The capacity shortage appears most concentrated around the Feynman timeline, which occupies a more distant position on the company’s product roadmap.
Taiwan Semiconductor has confirmed the surge in customer demand and indicated intentions to expand manufacturing capabilities progressively. The company has yet to provide specific timelines regarding when the current production bottleneck might ease.
Certain industry observers have mentioned Intel and Samsung as possible alternative manufacturing partners, though neither competitor currently delivers TSMC’s leading-edge production capabilities at comparable volume.
Financial analysts following NVDA maintain optimistic long-term outlooks. TipRanks data shows the stock holds a Strong Buy consensus rating from 41 analysts, with a single Hold rating. The consensus price target reaches $274.03, suggesting approximately 58.7% potential upside from present trading levels.
NVDA closed down 3.28% Monday. TSM finished the session down 2.82%.
